XML 42 R27.htm IDEA: XBRL DOCUMENT v3.7.0.1
SHAREHOLDERS' EQUITY (DEFICIT) (Tables)
12 Months Ended
Dec. 31, 2016
SHAREHOLDERS' EQUITY  
Schedule of share capital

                                                                                                                                                                                    

 

 

December 31, 2016

 

December 31, 2015

 

 

 

Authorized

 

Issued and
outstanding

 

Authorized

 

Issued and
outstanding

 

Ordinary share of NIS 0.01 par value

 

 

50,000,000 

 

 

20,139,826 

 

 

50,000,000 

 

 

13,585,810 

 

​  

​  

​  

​  

​  

​  

​  

​  

Total

 

 

50,000,000 

 

 

20,139,826 

 

 

50,000,000 

 

 

13,585,810 

 

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

 

Schedule of stock options roll forward

                                                                                                                                                                                    

 

 

Number of
options

 

Weighted
average
exercise
price

 

Weighted
average
remaining
contractual
life

 

Aggregate
intrinsic
value

 

 

 

 

 

$

 

(years)

 

$

 

Options outstanding at January 1, 2016

 

 

1,247,185

 

 

4.39

 

 

5.78

 

 

8.99

 

Options granted

 

 

456,870

 

 

2.94

 

 

 

 

 

 

 

Options expired

 

 

(14,500

)

 

3.18

 

 

 

 

 

 

 

​  

​  

Options outstanding at end of year

 

 

1,689,555

 

 

4.02

 

 

6.06

 

 

 

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

Options vested and expected to be vested at end of year

 

 

1,672,623

 

 

4.03

 

 

6.03

 

 

 

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

Options vested at end of year

 

 

945,260

 

 

4.20

 

 

4.27

 

 

 

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

 

Schedule of options outstanding based on exercise price

                                                                                                                                                                                    

Exercise price

 

Options
outstanding as of
December 31,
2016

 

Weighted average
remaining
contractual term

 

Options
vested as of
December 31,
2016

 

Weighted average
remaining
contractual term

 

 

 

 

 

(years)

 

 

 

(years)

 

 

2.70

 

 

35,000 

 

 

9.98 

 

 

 

 

 

 

 

2.74

 

 

312,780 

 

 

9.46 

 

 

 

 

 

 

 

3.40

 

 

35,000 

 

 

9.92 

 

 

 

 

 

 

 

3.59

 

 

5,000 

 

 

9.75 

 

 

 

 

 

 

 

3.61

 

 

772,136 

 

 

3.64 

 

 

684,434 

 

 

3.50 

 

 

3.64

 

 

13,000 

 

 

9.72 

 

 

 

 

 

 

 

3.80

 

 

25,000 

 

 

9.89 

 

 

 

 

 

 

 

3.85

 

 

23,250 

 

 

9.76 

 

 

 

 

 

 

 

3.96

 

 

5,178 

 

 

4.78 

 

 

5,178 

 

 

4.78 

 

 

4.38

 

 

3,500 

 

 

8.57 

 

 

1,459 

 

 

8.57 

 

 

5.55

 

 

5,000 

 

 

8.57 

 

 

2,084 

 

 

8.57 

 

 

5.60

 

 

200,100 

 

 

8.60 

 

 

83,382 

 

 

8.60 

 

 

5.84

 

 

248,798 

 

 

5.07 

 

 

165,817 

 

 

5.07 

 

 

7.45

 

 

5,813 

 

 

8.44 

 

 

2,906 

 

 

8.44 

 

​  

​  

​  

​  

​  

​  

​  

​  

 

 

 

 

1,689,555 

 

 

6.06 

 

 

945,260 

 

 

4.27 

 

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

 

Schedule of the assumptions used to estimate the fair values of the options granted

                                                                                                                                                                                    

 

 

Year ended December 31

 

 

2016

 

2015

Volatility

 

79.7% - 98.78%

 

61.1% - 61.49%

Risk-free interest rate

 

1.25% - 2.17%

 

1.17% - 1.97%

Dividend yield

 

0%

 

0%

Expected life (years)

 

5.87

 

4.33 - 5.91

 

Schedule of total compensation cost related to all of the Company's equity-based awards

                                                                                                                                                                                    

 

 

Year ended
December 31,

 

 

 

2016

 

2015

 

Research and development

 

$

129 

 

$

145 

 

Sales and Marketing

 

 

10 

 

 

11 

 

General and administrative

 

 

694 

 

 

427 

 

​  

​  

​  

​  

 

 

$

833 

 

$

583 

 

​  

​  

​  

​  

​  

​  

​  

​